Dermatology transition questions deserve specialty-specific answers.

Start with the economics that can be explained

A physician practice should not be valued from collections alone. A planning discussion begins with collected revenue, ordinary operating expense, and the cost of replacing the owner's clinical labor. It then tests whether demand, staffing, referral relationships, payer access, systems, and continuity processes can remain useful after the owner steps away.

For dermatology, an owner should gather recent financial statements, payer mix, staffing roles, EHR and billing workflows, lease and vendor obligations, referral summaries, and the specialty evidence described below. The objective is not to disclose clinical data. It is to make the operating practice understandable.

The dermatology diligence file

The following issues often determine whether an interested successor can become a viable transition path:

• Medical, Mohs, and cosmetic revenue split. Document the relevant operating facts and identify what still requires professional review.
• Surveillance and pathology workflows. Document the relevant operating facts and identify what still requires professional review.
• Device and inventory schedules. Document the relevant operating facts and identify what still requires professional review.
• Referral and staffing continuity. Document the relevant operating facts and identify what still requires professional review.

What remains separate from core practice value

Cosmetic products, device value, and pathology-related economics are treated separately from the core medical practice range. A credible early Workup should show these items as separate considerations, identify the documents required to evaluate them, and avoid turning uncertain asset economics into an unsupported multiple.

Continuity before introductions

The owner should map notification responsibility, records access, coverage, credentialing, referrals, staffing, and specialty-specific care continuity before disclosing identity or initiating a serious process. This planning can be done with aggregate business and operational information. Patient-level information is not appropriate for the initial Doc2Doc intake.

Questions to bring to advisors

• Which source financial documents and adjustments are required to normalize operating economics?
• Which payer, privilege, license, lease, vendor, and separate-asset terms may affect timing or transferability?
• What continuity and records obligations apply in the relevant state and clinical setting?
• Which transition path is defensible now, and which evidence would change that view?